When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Change to section 6.5 Addition of 20 pack sizes for prefilled syringe with 2 separate needles presentation.
Change to section 10 Date of revision updated.
· Section 1 - update to name
· Section 2 - words updated for clarification
· Section 3 - updated to include description of pharmaceutical form
· Section 4.2 Primary vaccination - the need of the 4th dose at 12 months has been
reinforced, when the compressed administration schedule 0, 1, 2 and 12 months is used.
· Section 4.2 Immunocompromised vaccinees, Revaccination of non-responders and Special dosage recommendation for known of presumed exposure to hepatitis B virus - the recommendations for serologic testing, and administration of additional doses if needed have been strengthened.
· Section 4.2 Method of administration - updated to ensure vaccine not injected intravascularly and reference to see section 6.6 for instructions for preparation.
· Section 4.5 – inclusion of a sentence regarding concomitant administration
· Section 4.7 – wording change for clarification.
· Section 5.1 – additional information provided on clinical trials and booster doses.
· Section 6.2 – wording change for clarification
· Section 6.6 – inclusion of additional sentence with regards to disposal of waste.
· Section 10 – update to date of revision of the text